HopeStage
Back to all studies
RecruitingNCT07423273

Hyperbaric oxygen therapy for depression after stroke

About this titleRead the official source — NCT07423273
Device studyAges 50–85Israel
The study in practice

Understand this study

Who could participate?

Listed age limits: 50 years to 85 years.

Listed locations
ZrifinSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: November 8, 2023
Recruitment status
Recruiting
Enrollment listed in the registry
142
Sponsor
Assaf-Harofeh Medical Center
Sponsor type
Hospital / academic medical center
Study type
Device
Intervention type
Device
Locations
Israel
Age range
From 50 Years to 85 Years
Official registry ID
NCT07423273
Official title
Show the full official title

Hyperbaric Oxygen Therapy for Persistent Post Stroke Depression: A Prospective, Randomized, Double Blind Study

Recruitment & locations

Currently recruiting

Zrifin

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Assaf-Harofeh Medical Center, a hospital or academic medical center.

Who can participate?

Listed age limits: 50 years to 85 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies